4LBA Cabozantinib versus everolimus in patients with advanced renal cell carcinoma: Results of the randomized phase 3 METEOR trial
Choueiri, T, Escudier, B, Powles, T, Mainwaring, P, Rini, B, Donskov, F, Hammers, H, Hutson, T, Roth, B, Peltola, K, Lee, J.L, Heng, D, Schmidinger, M, Borgman-Hagey, A, Hessel, C, Scheffold, C, Schwab, G, Tannir, N, Motzer, R
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Abou-Alfa, Ghassan K, Meyer, Tim, Cheng, Ann-Lii, El-Khoueiry, Anthony B, Rimassa, Lorenza, Ryoo, Baek-Yeol, Cicin, Irfan, Merle, Philippe, Chen, YenHsun, Park, Joong-Won, Blanc, Jean-Frederic, Bolondi, Luigi, Klümpen, Heinz-Josef, Chan, Stephen L, Zagonel, Vittorina, Pressiani, Tiziana, Ryu, Min-Hee, Venook, Alan P, Hessel, Colin, Borgman-Hagey, Anne E, Schwab, Gisela, Kelley, Robin K
Published in The New England journal of medicine (05.07.2018)
Published in The New England journal of medicine (05.07.2018)
Get full text
Journal Article
156 ANALYSIS OF A TARGETED RECEPTOR TYROSINE KINASE INHIBITOR IN THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA
Menzel, L. P., Shankar, D. B., Shah, N. P., Hummerickhouse, R., Hagey, A., Sakamoto, K. M., Moore, T. B.
Published in Journal of investigative medicine (01.01.2005)
Published in Journal of investigative medicine (01.01.2005)
Get full text
Journal Article
833TiPPhase III (COSMIC-312) study of cabozantinib (C) in combination with atezolizumab (A) vs sorafenib (S) in patients (pts) with advanced hepatocellular carcinoma (aHCC) who have not received previous systemic anticancer therapy
Rimassa, L, Cheng, A-L, Braiteh, F, Chaudhry, A, Benzaghou, F, Thuluvath, P, Hazra, S, Borgman-Hagey, A E, Tan, B, Kayali, Z K, Zhu, A X, Kelley, R K
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
678PDOutcomes based on plasma biomarkers for the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (aHCC)
Rimassa, L, Kelley, R K, Meyer, T, Ryoo, B-Y, Merle, P, Park, J-W, Blanc, J-F, Lim, H Y, Tran, A, Borgman-Hagey, A E, Clary, D O, Wang, E, Cheng, A-L, El-Khoueiry, A B, Abou-Alfa, G K
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
The Pharmacokinetics and Safety of ABT-751, a Novel, Orally Bioavailable Sulfonamide Antimitotic Agent: Results of a Phase 1 Study
HANDE, Kenneth R, HAGEY, Anne, ROTHENBERG, Mace L, BERLIN, Jordan, YINGNA CAI, MEEK, Kysa, KOBAYASHI, Hiro, LOCKHART, A. Craig, MEDINA, Diane, SOSMAN, Jeffrey, GORDON, Gary B
Published in Clinical cancer research (01.05.2006)
Published in Clinical cancer research (01.05.2006)
Get full text
Journal Article
Phase 1 Study of ABT-751, a Novel Microtubule Inhibitor, in Patients with Refractory Hematologic Malignancies
YEE, Karen W. L, HAGEY, Anne, FERRAJOLI, Alessandra, ALBITAR, Maher, MCKEEGAN, Evelyn, GRIMM, David R, MUELLER, Toby, HOLLEY-SHANKS, Rhonda R, SAHELIJO, Leonardo, GORDON, Gary B, KANTARJIMI, Hagop M, GILES, Francis J, VERSTOVSEK, Srdan, CORTES, Jorge, GARCIA-MANERO, Guillermo, O'BRIEN, Susan M, FADERL, Stefan, THOMAS, Deborah, WIERDA, William, KORNBLAU, Steven
Published in Clinical cancer research (15.09.2005)
Published in Clinical cancer research (15.09.2005)
Get full text
Journal Article
The pharmacokinetics (PK) and pharmacodynamics (PD) of ABT-751 in children with recurrent neuroblastoma or other solid tumors
Fox, E., Widemann, B. C., Maris, J. M., Cohn, S. L., Xiong, H., Krivoshik, A. P., Hagey, A. E., Adamson, P. C., Balis, F. M.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
A phase I trial of ABT-751 and carboplatin (C) in patients (pts) with previously treated non-small cell lung cancer (NSCLC)
Dragnev, K. H., Rigas, J. R., Disalvo, W. M., Simeone, S. A., Hagey, A. E., Gordon, G. B., Dmitrovsky, E.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
Preliminary phase 2 results of ABT-751 in subjects with advanced renal cell carcinoma (RCC)
Hagey, A. E., Figlin, R. A., Moldawer, N., Sosman, J. A., Chi, K. N., Medina, D. M., Meek, K. A., Cernohous, P., Gordon, G. B.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article
Preliminary results of a phase 2 study of ABT-751 in patients (pts) with taxane-refractory non-small cell lung carcinoma (NSCLC)
Mauer, A. M., Szeto, L., Belt, R. J., Schwartzberg, L. S., Hagey, A., Coates, A. I., Meek, K. A., Cernohous, P., Gordon, G. B.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article
Phase I trial of oral ABT-751 in pediatric patients: Preliminary evidence of activity in neuroblastoma (NBL)
Fox, E., Adamson, P. C., Hagey, A., Widemann, B. C., Maris, J. M., Cohn, S. L., Cai, Y., Medina, D. M., Meek, K. A., Balis, F. M.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article
Phase 2 study of ABT-751 in patients with refractory metastatic colorectal carcinoma (CRC)
Benson, A. B., Kindler, H. L., Jodrell, D., Hagey, A., Coates, A. I., Meek, K. A., Cernohous, P., Gordon, G. B.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article
Phase 2 results of ABT-751 in subjects with taxane-refractory breast cancer: Interim analysis
Washington, D. K., Storniolo, A. M. V., Saleh, M., Tan-Chiu, E., Hagey, A., Medina, D. M., Meek, K. A., Cernohous, P., Gordon, G. B.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article